Navigation Links
Intensity modulated proton therapy reduces need for feeding tubes by 50 percent
Date:9/25/2013

ATLANTA, GA A new study from researchers at The University of Texas MD Anderson Proton Therapy Center found that the use of feeding tubes in oropharyngeal carcinoma (OPC) cancer patients treated with intensity modulated proton therapy (IMPT) decreased by more than 50 percent compared to patients treated with intensity modulated radiation therapy (IMRT). This suggests that proton therapy may offer vital quality of life benefits for patients with tumors occurring at the back of the throat.

The results, presented today by the lead researcher, Steven J. Frank, M.D., associate professor of Radiation Oncology at MD Anderson at the American Society for Radiation Oncology's 55th Annual Meeting, also indicate that toxicity levels in OPC patients treated with IMPT are much lower than those treated with IMRT.

IMPT, one of the most advanced forms of proton therapy, delivers a precise dose of protons to tumors embedded in the "nooks and crannies" of the head and neck, including the base of tongue and tonsils. MD Anderson treated its first IMPT patient in 2011 and since approximately 150 patients, many with complex head and neck malignancies, have been treated with this form of proton therapy. Unlike IMRT, which destroys both cancerous and healthy cells, IMPT has the ability to destroy cancer cells while sparing surrounding healthy tissue from damage. Therefore, important quality of life outcomes such as neurocognitive function, vision, swallowing, hearing, taste and speech can be preserved in head and neck patients.

"IMPT is especially well-suited for patients with the most complicated tumors of the head and neck, precisely painting the protons onto the tumor layer by layer," said Frank. "In this way, the treatment team can confine the majority of the tumor-damaging energy to target areas and work to protect normal structures such as the oral cavity and brainstem."

OPC cancer develops in the part of the throat just behind the mouth. The American Cancer Society estimates that 36,000 people in the U.S. are diagnosed with cancer of the oral cavity and oropharynx each year (approximately a 20 percent increase since 2010). OPC cancer in most cases is linked to infection with human papilloma virus (HPV) and it's estimated that nearly 70 percent of OPC cancers are HPV-positive.

MD Anderson researchers evaluated 25 OPC patients treated with IMPT and 25 OPC patients treated with IMRT as part of the study. Five patients treated with IMPT required the use of feeding tubes (20 percent) compared to 12 patients treated with IMRT (48 percent). IMPT patients were spared from other serious side effects caused by the toxicity of IMRT such as vomiting, nausea, hearing problems, and mucositis (inflammation and ulceration of the digestive track). In addition, patients could better sustain their nutrition and hydration levels, often leading to faster recovery during and after treatment.

"With a recent epidemic of HPV-associated head and neck cancer among U.S. adults, there is a critical need to minimize the side effects associated with conventional IMRT that affects the patients' courses of treatments, and, ultimately, the rest of their lives," said Frank. "Since radiation therapy is the main tool to treat the disease in this fairly young group of patients, we must understand if more advanced technologies will provide additional value to this patient population."

Based on the results of this study, a Phase II/III randomized trial of IMPT vs. IMRT for the treatment of oropharyngeal cancer of the head and neck is underway at MD Anderson. Over the next five years, MD Anderson aims to enroll 360 patients in the trial, evaluating proton's ability to reduce toxicity across a range of known side effects and enhance long-term cancer survivorship when compared to conformal radiation therapy.


'/>"/>

Contact: Agata Porter
agata.porter@gabbe.com
212-220-4444
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Related medicine news :

1. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
2. Muscular Development Store Releases the Optimum Performance Workout for High Intensity Training
3. Viewing terrorist attacks on TV increases pain intensity -- Ben-Gurion U. researchers
4. Reduced intensity regimen prior to marrow transplant better for older leukemia patients
5. Pain Intensity May Help Differentiate 2 Skin Cancers
6. Smoking intensity and cancer markers predict seriousness of bladder cancer
7. Intensity modulated radiotherapy reduces side effects in patients with early breast cancer
8. Moderate-intensity walking timed just right might help protect against Type 2 diabetes
9. Proton therapy treatment preserves quality of life for men with prostate cancer
10. Horner Flooring to provide court for the MD Anderson Proton Therapy Showcase in Houston.
11. Penn Medicine study: Proton therapy cuts side effects for pediatric head and neck cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... The ... program for mid-market executives as a kick-off to the fifth annual CEO Connection ... 2017 on the University of Pennsylvania campus, followed by the two-day convention, which ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. (the ... two year study conducted by the University of Saskatchewan in partnership with PotashCorp, ... potash brine-impacted groundwater. As a part of the study, batch adsorption experiments were ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... ... protection assistance and financial consultations to communities in northern Virginia and DC, is ... to help provide for patients with Alzheimer’s and other disorders that lead to ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 percent ... data released today by the American Society for Dermatologic Surgery (ASDS). ... percentage of consumers considering a cosmetic medical procedure has doubled since 2013. , ...
(Date:6/27/2017)... ... 27, 2017 , ... Salucro, the cloud-based payment platform that ... hospitals and provider groups, has announced that it will now offer Parasail’s payment ... a San Francisco health-finance startup that has launched a series of tech-based products ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... , June 16, 2017 Datascope Corp. is voluntarily performing ... Corp. for a potential electrical test failure code.     ... PART NUMBER ... CS300 IABP 0998-UC-0446HXX; ... This ...
(Date:6/13/2017)... Ind. , June 13, 2017 Zimmer Biomet ... musculoskeletal healthcare, today announced that the U.S. Food and Drug ... dated June 3, 2015 relating to its Zhejiang, ... "The successful clearance of the ... manufacturing facility is a measure of the progress ...
(Date:6/9/2017)... , June 9, 2017 More than ... further effort to help spread lessons learned from clinical ... International Diabetes Federation (IDF) and Eli Lilly and Company ... the second phase of the Bringing Research in Diabetes ... their commitment to helping people with diabetes effectively manage ...
Breaking Medicine Technology: